Abzu

Abzu

Investigación biotecnológica

Nordhavn, Capital Region 4530 seguidores

Abzu is the best in class in silico disease understanding and drug design company.

Sobre nosotros

Abzu is the best in class in silico disease understanding and drug design company. Since its founding in 2018, Abzu’s proprietary explainable AI, the QLattice®, has been the cornerstone to their cutting-edge approach. Abzu is a preferred partner for pharma, biotech, and research institutions, transforming data into insights and accelerating R&D. Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to Cool Vendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards.

Sitio web
http://abzu.ai
Sector
Investigación biotecnológica
Tamaño de la empresa
De 11 a 50 empleados
Sede
Nordhavn, Capital Region
Tipo
De financiación privada
Fundación
2018
Especialidades
RNA Therapeutics, RNA Tx, AI, artificial intelligence, explainable AI, trustworthy AI, QLattice, drug development, pharma y pharma R&D

Ubicaciones

  • Principal

    Orient Plads 1

    Mezzanine

    Nordhavn, Capital Region 2150, DK

    Cómo llegar
  • c/o Carrer d’Àlaba

    100

    Barcelona, 08018, ES

    Cómo llegar

Empleados en Abzu

Actualizaciones

Páginas similares

Financiación

Abzu 5 rondas en total

Última ronda

Otorgar

2.609.298,00 US$

Ver más información en Crunchbase